Scenic Biotech
5 known investors
Find your way into Scenic Biotech
Scenic Biotech develops modifier therapy, a genetic medicine approach that targets secondary functions in the genome to neutralize the impact of disease-causing mutations. The company uses its proprietary Cell-seq platform to develop small molecule programs for genetic disorders.
Investors · 5
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AMar 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
3 people who came through Scenic Biotech went on to found or lead other companies.
In the news
Frequently asked questions
- What does Scenic Biotech do?
- Scenic Biotech develops modifier therapy, a genetic medicine approach that targets secondary functions in the genome to neutralize the impact of disease-causing mutations. The company uses its proprietary Cell-seq platform to develop small molecule programs for genetic disorders.
- Who are Scenic Biotech's investors?
- Scenic Biotech's investors include BioMedPartners, EIR Ventures, Oxford Science Enterprises, BioGeneration Ventures, Inkef.